CIK: 1619731 - Address: C/o Eyegate Pharmaceuticals, Inc., 271 Waverley Oaks Road, Suite 108, Waltham, MA 02452
5 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret113-1-7-21-49-490-25
S%wins6710010010010093

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/6/19 18:45
12/6/19
EYEGEyegate Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGoldberg MortonMADS-146.930-2-1000D
11/13/19 16:18
11/12/19
EYEGEyegate Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGoldberg MortonMADS-94.290-2-512D
3/6/17 16:05
3/6/17
EYEGEyegate Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGoldberg MortonMADS-273.008-9-499D-51-24657281791510-4-8-15
6/15/16 17:10
6/15/16
EYEGEyegate Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGoldberg MortonMADS-473.160-15-4617D-3315-7-9-12-11-31-9-26-56-51
6/7/16 17:42
6/3/16
EYEGEyegate Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGoldberg MortonMADS.dm-363.310-11-2532D-2421-1069-9-10-5-22-42-46

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact